Retatrutide is not approved in the UK, so there is no official patient guidance yet
Talking to Your Doctor About New Weight Loss Medicines Patients interested in new weight loss treatments should speak to their GP about currently approved options such as semaglutide (Wegovy) or enquire about clinical trial eligibility through the NIHR 'Be Part of Research' website
Months 6-12: This is where the biggest changes happen for people who tolerate the medication well and reach therapeutic doses
Nevertheless, GLP1RAs did not statistically significantly improve systolic function, as demonstrated by Kumarathurai et al
Berberine, for example, has been shown to be associated with modest reductions in waist circumference and BMI and to help manage blood sugar levels in people with type 2 diabetes
Were here to ensure your weight loss journey is safe, comfortable, and tailored to your unique needs